OvaScience greenshoe exercised in $57.56 million public sale of stock

Leerink, Oppenheimer, H. C. Wainwright, Roth, JonesTrading assisted

By Devika Patel

Knoxville, Tenn., June 1 – OvaScience, Inc. said the underwriters for its public offering of stock opted to exercise the deal’s $7.51 million greenshoe in full, lifting total proceeds of the offering to $57.56 million. The deal was announced May 25 and priced for $50.05 million with the greenshoe on May 26.

The company sold 8,222,500 common shares at $7.00 per share. The price per share is a 28.43% discount to the May 25 closing share price of $9.78. Of the shares, 1,072,500 were part of the fully exercised greenshoe.

Leerink Partners, LLC was the bookrunner.

Proceeds will be used for the commercial expansion of the Augment treatment, pre-commercial activities and working capital and other general corporate purposes.

Based in Cambridge, Mass., OvaScience is a fertility company focused on new treatments for infertility.

Issuer:	OvaScience, Inc.
Issue:	Common stock
Amount:	$57,557,500, including $7,507,500 greenshoe of 1,072,500 shares
Shares:	8,222,500
Price:	$7.00
Warrants:	No
Bookrunner:	Leerink Partners LLC
Co-managers:	Oppenheimer & Co. Inc., H. C. Wainwright & Co., Roth Capital Partners, LLC and JonesTrading Institutional Services LLC
Announcement date:	May 25
Pricing date:	May 26
Settlement date:	June 1
Stock symbol:	Nasdaq: OVAS
Stock price:	$9.78 at close May 25
Market capitalization:	$199.51 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.